Viewing Study NCT01366092

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2026-02-03 @ 1:39 AM
Study NCT ID: NCT01366092
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-11
First Post: 2011-06-02
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Graft-versus-host Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stem cell transplant View
None GVHD View
None bone marrow transplant View
None cord blood transplant View
None regulatory T cell View
None interleukin View